Suppr超能文献

肝外胆管癌的放射治疗

Radiation therapy in extrahepatic bile duct carcinoma.

作者信息

Mahe M, Romestaing P, Talon B, Ardiet J M, Salerno N, Sentenac I, Gerard J P

机构信息

Department of Radiation Therapy, Hôpital Lyon Sud, Pierre Benite, France.

出版信息

Radiother Oncol. 1991 Jun;21(2):121-7. doi: 10.1016/0167-8140(91)90084-t.

Abstract

Fifty-one patients with carcinoma of the extrahepatic bile ducts (EHBD) received radiation therapy between January 1980 and December 1988. The location of the tumors was: proximal third, 20 patients; middle third, 23 patients; distal third, 3; diffuse, 5 patients. Thirty-six patients underwent surgery with complete gross resection in 14 (10/14 with positive margins), incomplete gross resection in 12 and only biopsy in 10. Fifteen patients had only biliary drainage without laparotomy after cytologic diagnosis of malignancy in 11/15. Radiation therapy was done with curative intent after complete or incomplete resection (n = 26) and it was palliative in patients who had no resection or only biliary drainage (n = 25). Twenty-five patients received external radiation-therapy (ERT) alone to the tumor and lymph nodes (mean dose 45 Gy/2 Gy per fraction for cure, 35 Gy/10 fractions for palliation), 8 patients had only iridium-192 (192Ir) implant (50-60 Gy at a 1 cm radius for cure, 30 Gy for palliation), 17 patients had both ERT + 192Ir (ERT 42.5 Gy + 192Ir 10-15 Gy for cure; ERT 20 Gy/5 fractions + 192Ir 20-30 Gy for palliation) and one intra-operative irradiation + ERT. The overall survival for the entire group was 55, 28.5 and 15% at 12, 24, 36 months and median survival 12 months. Median survival was 22 months in patients treated with curative intent and only 10 months after palliative treatment (p 0.03). Among patients who had curative treatment, median survival was 27.5 months after complete gross resection and 13 months after incomplete gross resection (p 0.045).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

1980年1月至1988年12月期间,51例肝外胆管癌(EHBD)患者接受了放射治疗。肿瘤部位如下:近端三分之一段20例;中段三分之一段23例;远端三分之一段3例;弥漫性5例。36例患者接受了手术,其中14例实现大体完全切除(切缘阳性者10/14),12例大体不完全切除,10例仅行活检。15例患者在11/15经细胞学诊断为恶性肿瘤后,仅行胆道引流,未进行剖腹手术。在完全或不完全切除后(n = 26),放射治疗以治愈为目的进行,而对于未切除或仅行胆道引流的患者(n = 25)则为姑息性治疗。25例患者仅接受针对肿瘤和淋巴结的外照射放疗(ERT)(根治性治疗时平均剂量45 Gy,分2 Gy/次;姑息性治疗时35 Gy,分10次),8例患者仅接受铱-192(192Ir)植入(根治性治疗时在1 cm半径处给予50 - 60 Gy,姑息性治疗时给予30 Gy),17例患者接受ERT + 192Ir联合治疗(根治性治疗时ERT 42.5 Gy + 192Ir 10 - 15 Gy;姑息性治疗时ERT 20 Gy/5次 + 192Ir 20 - 30 Gy),还有1例接受术中放疗 + ERT。整个组在12、24、36个月时的总生存率分别为55%、28.5%和15%,中位生存期为12个月。根治性治疗患者的中位生存期为22个月,姑息性治疗后仅为10个月(p < 0.03)。在接受根治性治疗的患者中,大体完全切除后的中位生存期为27.5个月,大体不完全切除后的中位生存期为13个月(p < 0.045)。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验